NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-07-31
Reading CNXC? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Achieve full year revenue of $10.035B to $10.180B in FY 2026: metric not reported.
View ThesisRevenue growth is slowing — up about 4% over the past year and decelerating.
View GrowthMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 63% in its worst 12-month stretch.
View RiskConcentrix's growth has to keep compounding to justify the price, especially after trimming its 2026 revenue outlook. The latest results showed sales in line with estimates, but the stock dropped 24%, indicating market concerns about future growth. It trades at 2.3× P/E versus a peer median of 24×, suggesting that expectations look modest compared to our view. The primary risk is the failure to achieve full-year revenue of $10.035B to $10.180B in FY 2026, with a miss probability of 22%. Peer multiples imply a price about 71% above where it trades. This read is provisional.
Trailing returns as of 2026-07-31. CNXC is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 4 analysts currently covering CNXC (as of Jul 2026).
Based on 3 Wall Street analysts offering 12-month price targets for CNXC in the last 4 months.
A consensus fair price across 5 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Data Processing & Outsourced Services — fair value, gap to price, and forward P/E.
Significant share price decline indicates market concerns.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
Current $24.60
The last 12 months of price, then the range of analyst 12-month targets from today’s $24.60.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Achieve $10.035B to $10.180B revenue in FY 2026
Trimming 2026 outlook impacts revenue growth expectations.
Threatens: Achieve $10.035B to $10.180B revenue in FY 2026
Sales in line but stock drop indicates market concerns.
Earnings transcript likely provides key insights on revenue and EPS.
